SE7401958L - - Google Patents

Info

Publication number
SE7401958L
SE7401958L SE7401958A SE7401958A SE7401958L SE 7401958 L SE7401958 L SE 7401958L SE 7401958 A SE7401958 A SE 7401958A SE 7401958 A SE7401958 A SE 7401958A SE 7401958 L SE7401958 L SE 7401958L
Authority
SE
Sweden
Application number
SE7401958A
Other versions
SE388849B (sv
Inventor
E I Carlsson
N H A Persson
B R Samuelsson
K I L Wetterlin
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE7401958A priority Critical patent/SE388849B/xx
Priority to ZA00750381A priority patent/ZA75381B/xx
Priority to DE19752502993 priority patent/DE2502993A1/de
Priority to AT96475*#A priority patent/AT334881B/de
Priority to FI750390A priority patent/FI62055B/fi
Priority to DD184143A priority patent/DD118614A5/xx
Priority to AU78116/75A priority patent/AU497441B2/en
Priority to SU752104405A priority patent/SU603332A3/ru
Priority to CH169075A priority patent/CH616648A5/de
Priority to IE279/75A priority patent/IE41350B1/xx
Priority to FR7504553A priority patent/FR2261000B1/fr
Priority to CA220,014A priority patent/CA1052387A/en
Priority to NO750468A priority patent/NO140628C/no
Priority to GB6172/75A priority patent/GB1492647A/en
Priority to HUHE678A priority patent/HU169704B/hu
Priority to US05/549,841 priority patent/US4244969A/en
Priority to LU71846A priority patent/LU71846A1/xx
Priority to DK53975AA priority patent/DK135711B/da
Priority to BE153340A priority patent/BE825515A/xx
Priority to JP50018088A priority patent/JPS50116433A/ja
Priority to NL7501785A priority patent/NL7501785A/xx
Priority to CS75986A priority patent/CS202035B2/cs
Publication of SE7401958L publication Critical patent/SE7401958L/xx
Priority to SU762315654A priority patent/SU609460A3/ru
Priority to SU7602314963A priority patent/SU577971A3/ru
Priority to AT415076A priority patent/AT341498B/de
Priority to AT414976A priority patent/AT341497B/de
Publication of SE388849B publication Critical patent/SE388849B/xx
Priority to CS785579A priority patent/CS202036B2/cs
Priority to CS785580A priority patent/CS202037B2/cs
Priority to IT7950875A priority patent/IT7950875A0/it
Priority to US06/150,883 priority patent/US4336267A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
SE7401958A 1974-02-14 1974-02-14 Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan SE388849B (sv)

Priority Applications (30)

Application Number Priority Date Filing Date Title
SE7401958A SE388849B (sv) 1974-02-14 1974-02-14 Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
ZA00750381A ZA75381B (en) 1974-02-14 1975-01-20 Heart active compounds
DE19752502993 DE2502993A1 (de) 1974-02-14 1975-01-25 Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
AT96475*#A AT334881B (de) 1974-02-14 1975-02-10 Verfahren zur herstellung neuer 1-phenoxy-2-hydroxy-3-aminopropane und deren saureadditionssalze
FI750390A FI62055B (fi) 1974-02-14 1975-02-12 Foerfarande foer framstaellning av aminer som stimulerar hjaertats beta-receptorer
DD184143A DD118614A5 (de) 1974-02-14 1975-02-12
AU78116/75A AU497441B2 (en) 1974-02-14 1975-02-12 Heart active compounds
SU752104405A SU603332A3 (ru) 1974-02-14 1975-02-12 Способ получени алканоламинов или их солей в виде рацемата или оптически-активных антиподов
CH169075A CH616648A5 (de) 1974-02-14 1975-02-12
US05/549,841 US4244969A (en) 1974-02-14 1975-02-13 Heart active compounds
FR7504553A FR2261000B1 (de) 1974-02-14 1975-02-13
CA220,014A CA1052387A (en) 1974-02-14 1975-02-13 Heart active compounds
NO750468A NO140628C (no) 1974-02-14 1975-02-13 Analogifremgangsmaate for fremstilling av nye, terapeutisk virksomme aminer
GB6172/75A GB1492647A (en) 1974-02-14 1975-02-13 Substituted phenoxy propanolamines
HUHE678A HU169704B (de) 1974-02-14 1975-02-13
IE279/75A IE41350B1 (en) 1974-02-14 1975-02-13 Substituted phenoxypropanolamines
JP50018088A JPS50116433A (de) 1974-02-14 1975-02-14
CS75986A CS202035B2 (en) 1974-02-14 1975-02-14 Process for preparing new p-hydroxyphenoxypropanolamines
DK53975AA DK135711B (da) 1974-02-14 1975-02-14 Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer.
BE153340A BE825515A (fr) 1974-02-14 1975-02-14 Composes agissant sur le coeur
LU71846A LU71846A1 (de) 1974-02-14 1975-02-14
NL7501785A NL7501785A (nl) 1974-02-14 1975-02-14 Werkwijze ter bereiding van verbindingen die de werking van het hart beinvloeden, aldus bereide verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
SU762315654A SU609460A3 (ru) 1974-02-14 1976-01-20 Способ получени производных аминопропанола или их солей
SU7602314963A SU577971A3 (ru) 1974-02-14 1976-01-23 Способ получени производных пропаноламина или их солей
AT414976A AT341497B (de) 1974-02-14 1976-06-08 Verfahren zur herstellung neuer 1-phenoxy-2-hydroxy-3-aminopropane und deren saureadditionssalze
AT415076A AT341498B (de) 1974-02-14 1976-06-08 Verfahren zur herstellung neuer 1-phenoxy-2-hydroxy-3-aminopropane und deren saureadditionssalze
CS785579A CS202036B2 (en) 1974-02-14 1978-08-28 Process for preparing new p-hydroxyphenoxypropanolamines
CS785580A CS202037B2 (en) 1974-02-14 1978-08-28 Process for preparing new p-hydroxyphenoxypropanolamines
IT7950875A IT7950875A0 (it) 1974-02-14 1979-11-21 Composti dotati di attivita' di stimolo dei beta-recettori cardiaci eprocedimento per la loro preparazione
US06/150,883 US4336267A (en) 1974-02-14 1980-05-19 Heart active compounds and methods of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7401958A SE388849B (sv) 1974-02-14 1974-02-14 Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan

Publications (2)

Publication Number Publication Date
SE7401958L true SE7401958L (de) 1975-08-15
SE388849B SE388849B (sv) 1976-10-18

Family

ID=20320208

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7401958A SE388849B (sv) 1974-02-14 1974-02-14 Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan

Country Status (23)

Country Link
US (2) US4244969A (de)
JP (1) JPS50116433A (de)
AT (1) AT334881B (de)
AU (1) AU497441B2 (de)
BE (1) BE825515A (de)
CA (1) CA1052387A (de)
CH (1) CH616648A5 (de)
CS (2) CS202035B2 (de)
DD (1) DD118614A5 (de)
DE (1) DE2502993A1 (de)
DK (1) DK135711B (de)
FI (1) FI62055B (de)
FR (1) FR2261000B1 (de)
GB (1) GB1492647A (de)
HU (1) HU169704B (de)
IE (1) IE41350B1 (de)
IT (1) IT7950875A0 (de)
LU (1) LU71846A1 (de)
NL (1) NL7501785A (de)
NO (1) NO140628C (de)
SE (1) SE388849B (de)
SU (3) SU603332A3 (de)
ZA (1) ZA75381B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
EP0283540B1 (de) * 1987-03-26 1991-09-18 Helopharm W. Petrik GmbH & Co.KG. Verfahren zur Herstellung von 5-Hydroxydiprafenon und seiner Salze mit Säuren
SG99290A1 (en) * 1996-04-09 2003-10-27 Nps Pharma Inc Calcilytic compounds
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
US5966498A (en) * 1996-08-07 1999-10-12 Lakewood Engineering And Manufacturing Company End closure assembly for oil-filled heater
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
JP4604583B2 (ja) * 2004-07-20 2011-01-05 ダイソー株式会社 1−アミド−3−(2−ヒドロキシフェノキシ)−2−プロパノール誘導体、ならびに2−アミドメチル−1,4−ベンゾジオキサン誘導体の製造法
IL165365A0 (en) 2004-11-24 2006-01-15 Q Core Ltd Finger-type peristaltic pump
JP4934287B2 (ja) * 2005-04-05 2012-05-16 花王株式会社 美白剤
FR2916441B1 (fr) * 2007-05-22 2009-08-28 Clariant Specialty Fine Chem Procede de racemisation d'alpha-aminoacetals optiquement actifs.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (de) * 1962-12-11
GB1069345A (en) * 1963-07-19 1967-05-17 Ici Ltd New alkanolamine derivatives
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
BE790165A (fr) * 1971-12-14 1973-02-15 Parke Davis & Co Nouveaux aminoalcanols et procede pour les preparer

Also Published As

Publication number Publication date
CS202035B2 (en) 1980-12-31
JPS50116433A (de) 1975-09-11
AU497441B2 (en) 1978-12-14
IE41350B1 (en) 1979-12-19
NO750468L (de) 1975-08-15
DK53975A (de) 1975-10-06
IT7950875A0 (it) 1979-11-21
CH616648A5 (de) 1980-04-15
HU169704B (de) 1977-02-28
DK135711B (da) 1977-06-13
IE41350L (en) 1975-08-14
CA1052387A (en) 1979-04-10
FR2261000B1 (de) 1978-07-21
AU7811675A (en) 1976-08-12
BE825515A (fr) 1975-08-14
FR2261000A1 (de) 1975-09-12
AT334881B (de) 1977-02-10
NO140628C (no) 1979-10-10
GB1492647A (en) 1977-11-23
LU71846A1 (de) 1975-12-09
SE388849B (sv) 1976-10-18
FI750390A (de) 1975-08-15
ATA96475A (de) 1976-06-15
DE2502993A1 (de) 1975-09-04
NL7501785A (nl) 1975-08-18
ZA75381B (en) 1976-01-28
US4244969A (en) 1981-01-13
SU609460A3 (ru) 1978-05-30
DK135711C (de) 1977-11-21
US4336267A (en) 1982-06-22
FI62055B (fi) 1982-07-30
SU577971A3 (ru) 1977-10-25
CS202036B2 (en) 1980-12-31
SU603332A3 (ru) 1978-04-15
DD118614A5 (de) 1976-03-12
NO140628B (no) 1979-07-02

Similar Documents

Publication Publication Date Title
DK135711C (de)
AU495898B2 (de)
AU7463174A (de)
CH580969A5 (de)
BG19650A1 (de)
BG19770A1 (de)
BG19882A1 (de)
BG19893A1 (de)
BG20191A1 (de)
BG20667A1 (de)
BG20747A2 (de)
BG20853A1 (de)
BG21445A1 (de)
BG21452A1 (de)
BG21555A1 (de)
AU480209A (de)
BG21675A1 (de)
BG22207A1 (de)
BG22484A1 (de)
BG22583A1 (de)
BG23208A3 (de)
BG25978A3 (de)
CH1703874A4 (de)
CH565903A5 (de)
CH570940A5 (de)